Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
Holding KPTI?
Track your performance easily

Karyopharm Therapeutics (KPTI) Financial Statements

1,109 Followers

Karyopharm Therapeutics Financial Overview

Karyopharm Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.187; its P/E ratio is -0.62; Karyopharm Therapeutics is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 42.79M$ 33.13M$ 33.75M$ 36.01M$ 37.58M
Gross Profit$ 41.32M$ 31.21M$ 32.26M$ 35.10M$ 36.38M
EBIT$ 32.81M$ -31.41M-$ -28.42M$ -26.72M
EBITDA$ 35.21M$ -31.32M-$ -29.07M$ -27.46M
Net Income Common Stockholders$ 23.79M$ -37.36M$ -41.84M$ -34.51M$ -32.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 152.12M$ 148.58M$ 191.44M$ 208.31M$ 237.33M
Total Assets$ 213.98M$ 204.46M$ 240.44M$ 269.96M$ 297.83M
Total Debt$ 98.02M$ 176.44M$ 177.02M$ 177.56M$ 178.08M
Net Debt$ -54.11M$ 27.86M$ -14.43M$ -30.75M$ -59.25M
Total Liabilities$ 327.49M$ 373.41M$ 376.64M$ 370.36M$ 369.08M
Stockholders Equity$ -113.51M$ -168.96M$ -136.21M$ -100.40M$ -71.25M
Cash Flow-
Free Cash Flow$ -38.50M$ -43.92M-$ -29.53M$ -25.70M
Operating Cash Flow$ -38.50M$ -43.73M$ -18.59M$ -29.53M$ -25.70M
Investing Cash Flow$ 51.26M$ 21.94M$ 26.84M$ -7.68M$ 21.17M
Financing Cash Flow$ 40.97M-$ 264.00K-$ 860.00K
Currency in USD

Karyopharm Therapeutics Earnings and Revenue History

Karyopharm Therapeutics Debt to Assets

Karyopharm Therapeutics Cash Flow

Karyopharm Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis